BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35762150)

  • 1. Fat fraction quantification of bone marrow in the lumbar spine using the LiverLab assessment tool in healthy adult volunteers and patients with Gaucher disease.
    Gan C; Robertson PL; Lai JKC; Szer J
    Intern Med J; 2023 Jul; 53(7):1163-1169. PubMed ID: 35762150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaucher disease status and treatment assessment: pilot study using magnetic resonance spectroscopy bone marrow fat fractions in pediatric patients.
    Degnan AJ; Ho-Fung VM; Wang DJ; Ficicioglu C; Jaramillo D
    Clin Imaging; 2020 Jul; 63():1-6. PubMed ID: 32120306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience.
    Maas M; van Kuijk C; Stoker J; Hollak CE; Akkerman EM; Aerts JF; den Heeten GJ
    Radiology; 2003 Nov; 229(2):554-61. PubMed ID: 14526090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of Bone Marrow Involvement in Treated Gaucher Disease With Proton MR Spectroscopy: Correlation With Bone Marrow MRI Scores and Clinical Status.
    Jaramillo D; Bedoya MA; Wang DJ; Pena AH; Delgado J; Jaimes C; Ho-Fung V; Kaplan P
    AJR Am J Roentgenol; 2015 Jun; 204(6):1296-302. PubMed ID: 26001241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of IDEAL-IQ in Quantifying Femoral Bone Marrow Involvement in Gaucher Disease.
    Hou B; Cidanwangjiu ; Zhang H; Wang F; Qiu Z; Zhang Y; Jin Z
    J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):637-642. PubMed ID: 37382507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.
    Maas M; Hollak CE; Akkerman EM; Aerts JM; Stoker J; Den Heeten GJ
    AJR Am J Roentgenol; 2002 Oct; 179(4):961-5. PubMed ID: 12239046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-parametric MR imaging using apparent diffusion coefficient and fat fraction in quantification of bone marrow in pediatrics with Gaucher disease.
    Razek AAKA; Abdalla A; Barakat T; El-Taher H; Ali K
    Clin Imaging; 2018; 51():318-322. PubMed ID: 29958157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebra disc ratio as a parameter for bone marrow involvement and its application in Gaucher disease.
    Vlieger EJ; Maas M; Akkerman EM; Hollak CE; Den Heeten GJ
    J Comput Assist Tomogr; 2002; 26(5):843-8. PubMed ID: 12439326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers.
    Maas M; Akkerman EM; Venema HW; Stoker J; Den Heeten GJ
    J Comput Assist Tomogr; 2001; 25(5):691-7. PubMed ID: 11584227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.
    Hollak C; Maas M; Akkerman E; den Heeten A; Aerts H
    Blood Cells Mol Dis; 2001; 27(6):1005-12. PubMed ID: 11831867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned.
    van Dussen L; Akkerman EM; Hollak CE; Nederveen AJ; Maas M
    J Inherit Metab Dis; 2014 Nov; 37(6):1003-11. PubMed ID: 24924293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced vertebra to disk ratio as a new semi-quantitative imaging biomarker for Gaucher disease patients.
    Beaumont H; Maas M; Wormanns D; Zaim S; Klifa C; Faye N; Iannessi A
    Eur J Radiol; 2020 Aug; 129():109091. PubMed ID: 32497944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease.
    van Dussen L; Zimran A; Akkerman EM; Aerts JM; Petakov M; Elstein D; Rosenbaum H; Aviezer D; Brill-Almon E; Chertkoff R; Maas M; Hollak CE
    Blood Cells Mol Dis; 2013 Mar; 50(3):206-11. PubMed ID: 23199589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of chemical shift-encoded water-fat MRI and MR spectroscopy in quantification of marrow fat in postmenopausal females.
    Li G; Xu Z; Gu H; Li X; Yuan W; Chang S; Fan J; Calimente H; Hu J
    J Magn Reson Imaging; 2017 Jan; 45(1):66-73. PubMed ID: 27341545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment.
    Paskulin LD; Starosta RT; Bertholdo D; Vairo FP; Vedolin L; Schwartz IVD
    Blood Cells Mol Dis; 2021 Sep; 90():102591. PubMed ID: 34242856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraobserver and interobserver variability of the bone marrow burden (BMB) score for the assessment of disease severity in Gaucher disease. Possible impact of reporting experience.
    Lai JKC; Robertson PL; Goh C; Szer J
    Blood Cells Mol Dis; 2018 Feb; 68():121-125. PubMed ID: 28187999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients.
    Serai SD; Naidu AP; Andrew Burrow T; Prada CE; Xanthakos S; Towbin AJ
    Mol Genet Metab; 2018 Mar; 123(3):357-363. PubMed ID: 29361370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in bone marrow infiltration in patients with type I Gaucher disease treated with taliglucerase alfa.
    Zimran A; Dinur T; Revel-Vilk S; Akkerman EM; van Dussen L; Hollak CEM; Maayan H; Altarescu G; Chertkoff R; Maas M
    J Inherit Metab Dis; 2018 Nov; 41(6):1259-1265. PubMed ID: 30066229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical Approaches to Bone Marrow Fat Fraction Quantification Across Magnetic Resonance Imaging Platforms.
    Bainbridge A; Bray TJP; Sengupta R; Hall-Craggs MA
    J Magn Reson Imaging; 2020 Jul; 52(1):298-306. PubMed ID: 31944469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of fat content in vertebral marrow using a modified dixon sequence to differentiate benign from malignant processes.
    Yoo HJ; Hong SH; Kim DH; Choi JY; Chae HD; Jeong BM; Ahn JM; Kang HS
    J Magn Reson Imaging; 2017 May; 45(5):1534-1544. PubMed ID: 27690264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.